Creating an effective clinical registry for rare diseases

被引:33
作者
D'Agnolo, Hedwig M. A. [1 ]
Kievit, Wietske [2 ]
Andrade, Raul J. [3 ,4 ,5 ]
Karlsen, Tom Hemming [6 ]
Wedemeyer, Heiner [7 ]
Drenth, Joost P. H. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands
[3] Virgin Victory Univ Hosp, Inst Biomed Res Malaga IBIMA, Malaga, Spain
[4] Univ Malaga, Sch Med, Malaga, Spain
[5] Univ Malaga, Hosp Univ Virgen Victoria, Inst Invest Biomed Malaga, Unidad Gest Clin Aparato Digest,Ctr Invest Biomed, E-29071 Malaga, Spain
[6] Oslo Univ Hosp, Dept Transplantat Med, Div Canc Med Surg & Transplantat, Oslo, Norway
[7] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
关键词
Clinical registry; database; gastrointestinal disease; liver disease; liver transplantation; practical guide; rare diseases; rare liver disorders; registry design; PRIMARY BILIARY-CIRRHOSIS; REPORTED OUTCOME MEASURES; HEPATOCELLULAR-CARCINOMA; EPIDEMIOLOGY; MANAGEMENT; RISK;
D O I
10.1177/2050640615618042
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The exposure of clinicians to patients with rare gastrointestinal diseases is limited. This hurts clinical studies, which impedes accumulation of scientific knowledge on the natural disease course, treatment outcomes and prognosis in these patients. An excellent method to detect patterns on an aggregate level that would not be possible to discover in individual cases, is a registry study. This paper aims to describe a template to create a successful international registry for rare diseases. We focus mainly on rare hepatic diseases, but lessons from this paper serve other fields in medicine, as well.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 29 条
  • [1] Assessing patient reported outcome measures: A practical guide for gastroenterologists
    Alrubaiy, Laith
    Hutchings, Hayley A.
    Williams, John G.
    [J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2014, 2 (06) : 463 - 470
  • [2] [Anonymous], 2010, AHRQ PUBLICATION
  • [3] [Anonymous], 2005, Rare Diseases: understanding this Public Health Priority
  • [4] Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools
    Au, J. S.
    Navarro, V. J.
    Rossi, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (01) : 11 - 20
  • [5] Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: The consortium for radiologic imaging studies of polycystic kidney disease cohort
    Bae, Kyongtae T.
    Zhu, Fang
    Chapman, Arlene B.
    Torres, Vicente E.
    Grantham, Jared J.
    Guay-Woodford, Lisa M.
    Baumgarten, Deborah A.
    King, Bernard F., Jr.
    Wetzel, Louis H.
    Kenney, Philip J.
    Brummer, Marijn E.
    Bennett, William M.
    Klahr, Saulo
    Meyers, Catherine M.
    Zhang, Xiaoling
    Thompson, Paul A.
    Miller, J. Philip
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01): : 64 - 69
  • [6] Patient reported outcome measures could help transform healthcare
    Black, Nick
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [7] Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis
    Boonstra, Kirsten
    Weersma, Rinse K.
    van Erpecum, Karel J.
    Rauws, Erik A.
    Spanier, B. W. Marcel
    Poen, Alexander C.
    van Nieuwkerk, Karin M.
    Drenth, Joost P.
    Witteman, Ben J.
    Tuynman, Hans A.
    Naber, Anton H.
    Kingma, Paul J.
    van Buuren, Henk R.
    van Hoek, Bart
    Vleggaar, Frank P.
    van Geloven, Nan
    Beuers, Ulrich
    Ponsioen, Cyriel Y.
    [J]. HEPATOLOGY, 2013, 58 (06) : 2045 - 2055
  • [8] The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis
    Carbone, Marco
    Sharp, Stephen J.
    Flack, Steve
    Paximadas, Dimitrios
    Spiess, Kelly
    Adgey, Carolyn
    Griffiths, Laura
    Lim, Reyna
    Trembling, Paul
    Williamson, Kate
    Wareham, Nick J.
    Aldersley, Mark
    Bathgate, Andrew
    Burroughs, Andrew K.
    Heneghan, Michael A.
    Neuberger, James M.
    Thorburn, Douglas
    Hirschfield, Gideon M.
    Cordell, Heather J.
    Alexander, Graeme J.
    Jones, David E. J.
    Sandford, Richard N.
    Mells, George F.
    [J]. HEPATOLOGY, 2016, 63 (03) : 930 - 950
  • [9] Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid
    Carbone, Marco
    Mells, George F.
    Pells, Greta
    Dawwas, Muhammad F.
    Newton, Julia L.
    Heneghan, Michael A.
    Neuberger, James M.
    Day, Darren B.
    Ducker, Samantha J.
    Sandford, Richard N.
    Alexander, Graeme J.
    Jones, David E. J.
    [J]. GASTROENTEROLOGY, 2013, 144 (03) : 560 - +
  • [10] Natural Course and Survival of Neuroendocrine Tumors of Thymus and Lung in MEN1 Patients
    de Laat, Joanne M.
    Pieterman, Carolina R.
    van den Broek, Medard F.
    Twisk, Jos W.
    Hermus, Ad R.
    Dekkers, Olaf M.
    de Herder, Wouter W.
    van der Horst-Schrivers, Anouk N.
    Drent, Madeleine L.
    Bisschop, Peter H.
    Havekes, Bas
    Vriens, Menno R.
    Valk, Gerlof D.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (09) : 3325 - 3333